Journal
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 29, Issue 4, Pages 557-568Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.beem.2015.04.008
Keywords
estrogen receptors; cancer; metabolic disease
Categories
Funding
- Swedish Cancer Fund
- Robert A. Welch Foundation [E-0004]
Ask authors/readers for more resources
Estrogen receptors alpha (ER alpha) and beta (ER beta) are transcription factors that are involved in the regulation of many complex physiological processes in humans. Abnormal ER signaling leads to development of a variety of diseases, such as cancer, metabolic and cardiovascular disease, neurodegeneration, inflammation, and osteoporosis. This review provides an overview and update on ER alpha and ER beta in health and disease with focus on their role in cancer and metabolic disease and in the context of recent years' success in providing genome wide data on ER function. Furthermore, potential clinical applications and challenges are also discussed. (C) 2015 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available